A Traveler's Guide to Complex Carbohydrates in the Cyber Space
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The ELIXIR Core Data Resources: Fundamental Infrastructure for The
Supplementary Data: The ELIXIR Core Data Resources: fundamental infrastructure for the life sciences The “Supporting Material” referred to within this Supplementary Data can be found in the Supporting.Material.CDR.infrastructure file, DOI: 10.5281/zenodo.2625247 (https://zenodo.org/record/2625247). Figure 1. Scale of the Core Data Resources Table S1. Data from which Figure 1 is derived: Year 2013 2014 2015 2016 2017 Data entries 765881651 997794559 1726529931 1853429002 2715599247 Monthly user/IP addresses 1700660 2109586 2413724 2502617 2867265 FTEs 270 292.65 295.65 289.7 311.2 Figure 1 includes data from the following Core Data Resources: ArrayExpress, BRENDA, CATH, ChEBI, ChEMBL, EGA, ENA, Ensembl, Ensembl Genomes, EuropePMC, HPA, IntAct /MINT , InterPro, PDBe, PRIDE, SILVA, STRING, UniProt ● Note that Ensembl’s compute infrastructure physically relocated in 2016, so “Users/IP address” data are not available for that year. In this case, the 2015 numbers were rolled forward to 2016. ● Note that STRING makes only minor releases in 2014 and 2016, in that the interactions are re-computed, but the number of “Data entries” remains unchanged. The major releases that change the number of “Data entries” happened in 2013 and 2015. So, for “Data entries” , the number for 2013 was rolled forward to 2014, and the number for 2015 was rolled forward to 2016. The ELIXIR Core Data Resources: fundamental infrastructure for the life sciences 1 Figure 2: Usage of Core Data Resources in research The following steps were taken: 1. API calls were run on open access full text articles in Europe PMC to identify articles that mention Core Data Resource by name or include specific data record accession numbers. -
Bioinformatics Study of Lectins: New Classification and Prediction In
Bioinformatics study of lectins : new classification and prediction in genomes François Bonnardel To cite this version: François Bonnardel. Bioinformatics study of lectins : new classification and prediction in genomes. Structural Biology [q-bio.BM]. Université Grenoble Alpes [2020-..]; Université de Genève, 2021. En- glish. NNT : 2021GRALV010. tel-03331649 HAL Id: tel-03331649 https://tel.archives-ouvertes.fr/tel-03331649 Submitted on 2 Sep 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. THÈSE Pour obtenir le grade de DOCTEUR DE L’UNIVERSITE GRENOBLE ALPES préparée dans le cadre d’une cotutelle entre la Communauté Université Grenoble Alpes et l’Université de Genève Spécialités: Chimie Biologie Arrêté ministériel : le 6 janvier 2005 – 25 mai 2016 Présentée par François Bonnardel Thèse dirigée par la Dr. Anne Imberty codirigée par la Dr/Prof. Frédérique Lisacek préparée au sein du laboratoire CERMAV, CNRS et du Computer Science Department, UNIGE et de l’équipe PIG, SIB Dans les Écoles Doctorales EDCSV et UNIGE Etude bioinformatique des lectines: nouvelle classification et prédiction dans les génomes Thèse soutenue publiquement le 8 Février 2021, devant le jury composé de : Dr. Alexandre de Brevern UMR S1134, Inserm, Université Paris Diderot, Paris, France, Rapporteur Dr. -
Toolboxes for a Standardised and Systematic Study of Glycans
Campbell et al. BMC Bioinformatics 2014, 15(Suppl 1):S9 http://www.biomedcentral.com/1471-2105/15/S1/S9 RESEARCH Open Access Toolboxes for a standardised and systematic study of glycans Matthew P Campbell1, René Ranzinger2, Thomas Lütteke3, Julien Mariethoz4, Catherine A Hayes5, Jingyu Zhang1, Yukie Akune6, Kiyoko F Aoki-Kinoshita6, David Damerell7,11, Giorgio Carta8, Will S York2, Stuart M Haslam7, Hisashi Narimatsu9, Pauline M Rudd8, Niclas G Karlsson4, Nicolle H Packer1, Frédérique Lisacek4,10* From Integrated Bio-Search: 12th International Workshop on Network Tools and Applications in Biology (NETTAB 2012) Como, Italy. 14-16 November 2012 Abstract Background: Recent progress in method development for characterising the branched structures of complex carbohydrates has now enabled higher throughput technology. Automation of structure analysis then calls for software development since adding meaning to large data collections in reasonable time requires corresponding bioinformatics methods and tools. Current glycobioinformatics resources do cover information on the structure and function of glycans, their interaction with proteins or their enzymatic synthesis. However, this information is partial, scattered and often difficult to find to for non-glycobiologists. Methods: Following our diagnosis of the causes of the slow development of glycobioinformatics, we review the “objective” difficulties encountered in defining adequate formats for representing complex entities and developing efficient analysis software. Results: Various solutions already implemented and strategies defined to bridge glycobiology with different fields and integrate the heterogeneous glyco-related information are presented. Conclusions: Despite the initial stage of our integrative efforts, this paper highlights the rapid expansion of glycomics, the validity of existing resources and the bright future of glycobioinformatics. -
PROGRAM and ABSTRACTS for 2020 ANNUAL MEETING of the SOCIETY for GLYCOBIOLOGY November 9–12, 2020 Phoenix, AZ, USA 1017 2020 Sfg Virtual Meeting Preliminary Schedule
Downloaded from https://academic.oup.com/glycob/article/30/12/1016/5948902 by guest on 25 January 2021 PROGRAM AND ABSTRACTS FOR 2020 ANNUAL MEETING OF THE SOCIETY FOR GLYCOBIOLOGY November 9–12, 2020 Phoenix, AZ, USA 1017 2020 SfG Virtual Meeting Preliminary Schedule Mon. Nov 9 (Day 1) TOKYO ROME PACIFIC EASTERN EASTERN SESSION TIME TIME TIME START END TIME TIME 23:30 15:30 6:30 9:30 9:50 Welcome and Introduction - Michael Tiemeyer, CCRC UGA Downloaded from https://academic.oup.com/glycob/article/30/12/1016/5948902 by guest on 25 January 2021 23:30 15:30 6:30 9:50 – 12:36 Session 1: Glycobiology of Normal and Disordered Development | Chair: Kelly Ten-Hagen, NIH/NIDCR 23:50 15:50 6:50 9:50 10:10 KEYNOTE: “POGLUT1 mutations cause myopathy with reduced Notch signaling and α-dystroglycan hypoglycosylation” - Carmen Paradas Lopez, Biomedical Institute Sevilla 0:12 16:12 7:12 10:12 10:24 Poster Talk: “Regulation of Notch signaling by O-glycans in the intestine” – Mohd Nauman, Albert Einstein 0:26 16:26 7:26 10:26 10:38 Poster Talk: “Generation of an unbiased interactome for the tetratricopeptide repeat domain of the O-GlcNAc transferase indicates a role for the enzyme in intellectual disability” – Hannah Stephen, University of Georgia 0:40 16:30 7:30 10:40 10:50 Q&A 10:52 11:12 7:52 10:52 11:12 KEYNOTE: “Aberrations in N-cadherin Processing Drive PMM2-CDG Pathogenesis” - Heather Flanagan-Steet, Greenwood Genetics Center 1:14 11:26 8:14 11:14 11:26 Poster Talk: “Functional analyses of TMTC-type protein O-mannosyltransferases in Drosophila model -
Introduction to Bioinformatics (Elective) – SBB1609
SCHOOL OF BIO AND CHEMICAL ENGINEERING DEPARTMENT OF BIOTECHNOLOGY Unit 1 – Introduction to Bioinformatics (Elective) – SBB1609 1 I HISTORY OF BIOINFORMATICS Bioinformatics is an interdisciplinary field that develops methods and software tools for understanding biologicaldata. As an interdisciplinary field of science, bioinformatics combines computer science, statistics, mathematics, and engineering to analyze and interpret biological data. Bioinformatics has been used for in silico analyses of biological queries using mathematical and statistical techniques. Bioinformatics derives knowledge from computer analysis of biological data. These can consist of the information stored in the genetic code, but also experimental results from various sources, patient statistics, and scientific literature. Research in bioinformatics includes method development for storage, retrieval, and analysis of the data. Bioinformatics is a rapidly developing branch of biology and is highly interdisciplinary, using techniques and concepts from informatics, statistics, mathematics, chemistry, biochemistry, physics, and linguistics. It has many practical applications in different areas of biology and medicine. Bioinformatics: Research, development, or application of computational tools and approaches for expanding the use of biological, medical, behavioral or health data, including those to acquire, store, organize, archive, analyze, or visualize such data. Computational Biology: The development and application of data-analytical and theoretical methods, mathematical modeling and computational simulation techniques to the study of biological, behavioral, and social systems. "Classical" bioinformatics: "The mathematical, statistical and computing methods that aim to solve biological problems using DNA and amino acid sequences and related information.” The National Center for Biotechnology Information (NCBI 2001) defines bioinformatics as: "Bioinformatics is the field of science in which biology, computer science, and information technology merge into a single discipline. -
Representing Glycophenotypes: Semantic Unification of Glycobiology Resources for Disease Discovery
Representing glycophenotypes: semantic unification of glycobiology resources for disease discovery Authors: Jean-Philippe F. Gourdine1,2,3*, Matthew H. Brush1,3, Nicole A. Vasilevsky1,3, Kent Shefchek3,4, Sebastian Köhler3,5, Nicolas Matentzoglu3,6, Monica C. Munoz-Torres3,4, Julie A. McMurry3,4, Xingmin Aaron Zhang3,7, Melissa A. Haendel1,3,4 Affiliations: 1 Oregon Clinical & Translational Research Institute, Oregon Health & Science University, Portland, OR 97239, USA. 2 Oregon Health & Science University Library, Portland, OR 97239, USA. 3 Monarch Initiative, monarchinitiative.org. 4 Linus Pauling institute, Oregon State University, Corvallis, OR, USA. 5 Charité Centrum für Therapieforschung, Charité-Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin 10117, Germany. 6 European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Cambridge, UK. 7 The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA. Correspondence: [email protected] Abstract While abnormalities related to carbohydrates (glycans) are frequent for patients with rare and undiagnosed diseases as well as in many common diseases, these glycan-related phenotypes (glycophenotypes) are not well represented in knowledge bases (KBs). If glycan related diseases were more robustly represented and curated with glycophenotypes, these could be used for molecular phenotyping to help realize the goals of precision medicine. Diagnosis of rare diseases by computational cross-species comparison of genotype- phenotype data has been facilitated by leveraging ontological representations of clinical phenotypes, using Human Phenotype Ontology (HPO), and model organism ontologies such as Mammalian Phenotype Ontology (MP) in the context of the Monarch Initiative. In this article, we discuss the importance and complexity of glycobiology, and review the structure of glycan-related content from existing KBs and biological ontologies. -
Genbank Is a Reliable Resource for 21St Century Biodiversity Research
GenBank is a reliable resource for 21st century biodiversity research Matthieu Leraya, Nancy Knowltonb,1, Shian-Lei Hoc, Bryan N. Nguyenb,d,e, and Ryuji J. Machidac,1 aSmithsonian Tropical Research Institute, Smithsonian Institution, Panama City, 0843-03092, Republic of Panama; bNational Museum of Natural History, Smithsonian Institution, Washington, DC 20560; cBiodiversity Research Centre, Academia Sinica, 115-29 Taipei, Taiwan; dDepartment of Biological Sciences, The George Washington University, Washington, DC 20052; and eComputational Biology Institute, Milken Institute School of Public Health, The George Washington University, Washington, DC 20052 Contributed by Nancy Knowlton, September 15, 2019 (sent for review July 10, 2019; reviewed by Ann Bucklin and Simon Creer) Traditional methods of characterizing biodiversity are increasingly (13), the largest repository of genetic data for biodiversity (14, 15). being supplemented and replaced by approaches based on DNA In many cases, no vouchers are available to independently con- sequencing alone. These approaches commonly involve extraction firm identification, because the organisms are tiny, very difficult and high-throughput sequencing of bulk samples from biologically or impossible to identify, or lacking entirely (in the case of eDNA). complex communities or samples of environmental DNA (eDNA). In While concerns have been raised about biases and inaccuracies in such cases, vouchers for individual organisms are rarely obtained, often laboratory and analytical methods used in metabarcoding -
Genbank Dennis A
Published online 28 November 2016 Nucleic Acids Research, 2017, Vol. 45, Database issue D37–D42 doi: 10.1093/nar/gkw1070 GenBank Dennis A. Benson, Mark Cavanaugh, Karen Clark, Ilene Karsch-Mizrachi, David J. Lipman, James Ostell and Eric W. Sayers* National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Building 38A, 8600 Rockville Pike, Bethesda, MD 20894, USA Received September 15, 2016; Revised October 19, 2016; Editorial Decision October 24, 2016; Accepted November 07, 2016 ABSTRACT data from sequencing centers. The U.S. Patent and Trade- ® mark Office also contributes sequences from issued patents. GenBank (www.ncbi.nlm.nih.gov/genbank/)isa GenBank participates with the EMBL-EBI European Nu- comprehensive database that contains publicly avail- cleotide Archive (ENA) (2) and the DNA Data Bank of able nucleotide sequences for 370 000 formally de- Japan (DDBJ) (3) as a partner in the International Nu- Downloaded from scribed species. These sequences are obtained pri- cleotide Sequence Database Collaboration (INSDC) (4). marily through submissions from individual labora- The INSDC partners exchange data daily to ensure that tories and batch submissions from large-scale se- a uniform and comprehensive collection of sequence infor- quencing projects, including whole genome shotgun mation is available worldwide. NCBI makes GenBank data (WGS) and environmental sampling projects. Most available at no cost over the Internet, through FTP and a submissions are made using the web-based BankIt wide range of Web-based retrieval and analysis services (5). http://nar.oxfordjournals.org/ or the NCBI Submission Portal. GenBank staff assign accession numbers upon data receipt. -
Science& Technology Trends
����������������������������������������������� � ������������ ��������������������������� �������� � Life Sciences ������������� � �� ����� ������ Necessity of Research and Development � ���������������������������������������� ������� of the Structural Genome Analysis Technology � ���� � ���������������������� Necessity to Promote Glycoinformatics � ������� � ���������������������������� Information and Communication Technologies � Towards Human-Centered Ubiquitous Computing � ������ ������ – Using a Paradigm Change as a Chance to Strengthen � International Technological Competitiveness – ������������������������ � Research and Development Trends in Robot � �������������� Technology – Toward Promoting the Commercialization of Personal Robots – � �������� ������� Nanotechnology and Materials � ��������������������������� ����� Current Conditions and Issues in International Strategy from the Perspective of the International ������ Standardization of Materials Energy The Necessity, Actual Situation and Challenges ����������� of Human Resources Training in the Nuclear Field Manufacturing Technology �������� Trend in the Introduction and Development of Robotic Surgical Systems � ���������������������������� ��������������������������������������������������������� ��������������������������������� ��������� ����������� ������������������������������������� ������������������������������������������������������������ ��������������������������������������������������������������������� QUARTERLY REVIEW No.10 / January 2004 F o r e w o -
Meeting Booklet
LS2 Annual Meeting 2019 “Cell Biology from Tissue to Nucleus” Meeting Booklet 14-15 February, University of Zurich, Campus Irchel LS 2 - Life Sciences Switzerland Design by Dagmar Bocakova - [email protected] 2019 WELCOME ADDRESS Dear colleagues and friends It is with great pleasure that we invite you to the LS² Annual Meeting 2019, held on the 14th and 15th of February, 2019 at the Irchel Campus of the University of Zurich. This is a special year, as it is the 50th anniversary of USGEB/LS2, which we will celebrate with a Jubilee Apéro on Thursday 14th. The LS² Annual Meeting brings together scientists from all nations and backgrounds to discuss a variety of Life Science subjects. The meeting this year focusses on the cell in health and disease, with plenary talks on different aspects of cell biology and a symposium on live cell imaging approaches. You will be able to hear the latest, most exciting findings in several fields, from Molecular and Cellular Biosciences, Proteomics, Chemical Biology, Physiology, Pharmacology and more, presented by around 30 invited speakers and 45 speakers selected from abstracts in one of the seven scientific symposia and five plenary lectures. Two novelties highlight the meeting this year: The "PIs of Tomorrow" session, in which selected postdocs will present their research to a jury of professors, will be for the first time a plenary session. In addition, poster presenters will be selected to give flash talks in the symposia with the spirit to further promote young scientists. Join us for the poster session with more than 130 posters, combined with a large industry exhibition and the Jubilee Apéro. -
Biogrid Australia Facilitates Collaborative Medical And
SPECIAL ARTICLE Human Mutation OFFICIAL JOURNAL BioGrid Australia Facilitates Collaborative Medical and Bioinformatics Research Across Hospitals and Medical www.hgvs.org Research Institutes by Linking Data from Diverse Disease and Data Types Robert B. Merriel,1,2Ã Peter Gibbs,1–3 Terence J. O’Brien,1,4 and Marienne Hibbert4,5 1Melbourne Health, Melbourne, Australia; 2BioGrid Australia Ltd, Melbourne, Australia; 3Ludwig Institute for Cancer Research, Melbourne, Australia; 4Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, Australia; 5Victorian Partnership for Advanced Computing, Melbourne, Australia For the HVP Bioinformatics Special Issue Received 17 September 2010; accepted revised manuscript 14 December 2010. Published online in Wiley Online Library (www.wiley.com/humanmutation). DOI 10.1002/humu.21437 between institutions. Although there was a positive collective ABSTRACT: BioGrid Australia is a federated data linkage will—there were limited resources, a lack of standards and an and integration infrastructure that uses the Internet to inconsistent approach to data collection, storage and utilization enable patient specific information to be utilized for within and across Australian hospitals. research in a privacy protected manner, from multiple Market analysis plus consultations and workshops with research- databases of various data types (e.g. clinical, treatment, ers, clinicians and key government stakeholders defined the genomic, image, histopathology and outcome), from a ‘‘preferred future state’’ and a pilot system, the Molecular Medicine range of diseases (oncological, neurological, endocrine Informatics Model (MMIM) was proposed. The vision was a virtual and respiratory) and across more than 20 health services, platform, where information is accessible to authorized users, yet the universities and medical research institutes. -
Semantics of Data for Life Sciences and Reproducible Research[Version 1
F1000Research 2020, 9:136 Last updated: 16 AUG 2021 OPINION ARTICLE BioHackathon 2015: Semantics of data for life sciences and reproducible research [version 1; peer review: 2 approved] Rutger A. Vos 1,2, Toshiaki Katayama 3, Hiroyuki Mishima4, Shin Kawano 3, Shuichi Kawashima3, Jin-Dong Kim3, Yuki Moriya3, Toshiaki Tokimatsu5, Atsuko Yamaguchi 3, Yasunori Yamamoto3, Hongyan Wu6, Peter Amstutz7, Erick Antezana 8, Nobuyuki P. Aoki9, Kazuharu Arakawa10, Jerven T. Bolleman 11, Evan Bolton12, Raoul J. P. Bonnal13, Hidemasa Bono 3, Kees Burger14, Hirokazu Chiba15, Kevin B. Cohen16,17, Eric W. Deutsch18, Jesualdo T. Fernández-Breis19, Gang Fu12, Takatomo Fujisawa20, Atsushi Fukushima 21, Alexander García22, Naohisa Goto23, Tudor Groza24,25, Colin Hercus26, Robert Hoehndorf27, Kotone Itaya10, Nick Juty28, Takeshi Kawashima20, Jee-Hyub Kim28, Akira R. Kinjo29, Masaaki Kotera30, Kouji Kozaki 31, Sadahiro Kumagai32, Tatsuya Kushida 33, Thomas Lütteke 34,35, Masaaki Matsubara 36, Joe Miyamoto37, Attayeb Mohsen 38, Hiroshi Mori39, Yuki Naito3, Takeru Nakazato3, Jeremy Nguyen-Xuan40, Kozo Nishida41, Naoki Nishida42, Hiroyo Nishide15, Soichi Ogishima43, Tazro Ohta3, Shujiro Okuda44, Benedict Paten45, Jean-Luc Perret46, Philip Prathipati38, Pjotr Prins47,48, Núria Queralt-Rosinach 49, Daisuke Shinmachi9, Shinya Suzuki 30, Tsuyosi Tabata50, Terue Takatsuki51, Kieron Taylor 28, Mark Thompson52, Ikuo Uchiyama 15, Bruno Vieira53, Chih-Hsuan Wei12, Mark Wilkinson 54, Issaku Yamada 36, Ryota Yamanaka55, Kazutoshi Yoshitake56, Akiyasu C. Yoshizawa50, Michel